These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 38668609)

  • 21. Effects of botulinum toxin A and/or bimanual task-oriented therapy on upper extremity impairments in unilateral Cerebral Palsy: an explorative study.
    Speth L; Janssen-Potten Y; Leffers P; Rameckers E; Defesche A; Winkens B; Becher J; Smeets R; Vles JS
    Eur J Paediatr Neurol; 2015 May; 19(3):337-48. PubMed ID: 25661064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Optimal Dose of Botulinum Toxin A in Post-Stroke Lower Extremity Spasticity: A Systematic Review and Meta-Analysis.
    Doan TN; Kuo MY; Chou LW
    Toxins (Basel); 2021 Jun; 13(6):. PubMed ID: 34207357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Costs Among Patients with Spasticity or Cervical Dystonia in the US.
    Hull M; Anupindi VR; DeKoven M; He J; Bouchard J
    Adv Ther; 2023 Sep; 40(9):3986-4003. PubMed ID: 37414904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment goals in patients with post-stroke upper limb spasticity following injection of botulinum toxin A : Results of the German-Austrian subgroup of the ULIS-II study].
    Fheodoroff K; Dressler D; Woldag H; Koßmehl P; Koch M; Maisonobe P; Reichel G
    Nervenarzt; 2019 Apr; 90(4):361-370. PubMed ID: 30324541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences.
    Lorin K; Forsberg A
    Child Care Health Dev; 2016 Jul; 42(4):494-503. PubMed ID: 27198886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is botulinum toxin type A more effective and safer than other treatments for the management of lower limb spasticity in children with cerebral palsy? A Cochrane Review summary with commentary.
    Kim H; Kolaski K
    NeuroRehabilitation; 2021; 49(1):161-164. PubMed ID: 34366300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound Elastography to Assess Botulinum Toxin A Treatment for Post-stroke Spasticity: A Feasibility Study.
    Gao J; Rubin JM; Chen J; O'Dell M
    Ultrasound Med Biol; 2019 May; 45(5):1094-1102. PubMed ID: 30898386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BoNT-A related changes of cortical activity in patients suffering from severe hand paralysis with arm spasticity following ischemic stroke.
    Veverka T; Hluštík P; Tomášová Z; Hok P; Otruba P; Král M; Tüdös Z; Zapletalová J; Herzig R; Krobot A; Kaňovský P
    J Neurol Sci; 2012 Aug; 319(1-2):89-95. PubMed ID: 22687958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
    Dong Y; Wu T; Hu X; Wang T
    Eur J Phys Rehabil Med; 2017 Apr; 53(2):256-267. PubMed ID: 27834471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.
    López de Munain L; Valls-Solé J; Garcia Pascual I; Maisonobe P;
    Eur Neurol; 2019; 82(1-3):1-8. PubMed ID: 31726452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facts and de facto treatment of spasticity.
    Kim H; Stanford R
    J Pediatr Rehabil Med; 2020; 13(2):189-193. PubMed ID: 32568127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study.
    Khan P; Riberto M; Frances JA; Chueire R; Amorim ACFG; Xerez D; Chung TM; Mercuri LHC; Longo AL; Lianza S; Maisonobe P; Ruiz-Schutz VC
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33291807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).
    Turner-Stokes L; Ashford S; Jacinto J; Maisonobe P; Balcaitiene J; Fheodoroff K
    BMJ Open; 2016 Jun; 6(6):e011157. PubMed ID: 27315835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term treatment of spasticity with botulinum toxin type A: an analysis of 1221 treatments in 137 patients.
    Mohammadi B; Balouch SA; Dengler R; Kollewe K
    Neurol Res; 2010 Apr; 32(3):309-13. PubMed ID: 19726016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peri-operative Botulinum Neurotoxin injection to improve outcomes of surgeries on spastic limbs: A systematic review.
    Saeidiborojeni S; Mills PB; Reebye R; Finlayson H
    Toxicon; 2020 Dec; 188():48-54. PubMed ID: 33045238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R; Akturk S; Ersoy Y
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin A (BoNT-A) for spasticity in adults. What is the evidence?
    Moore AP
    Eur J Neurol; 2002 May; 9 Suppl 1():42-7; dicussion 53-61. PubMed ID: 11918649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triceps Surae Muscle Characteristics in Spastic Hemiparetic Stroke Survivors Treated with Botulinum Toxin Type A: Clinical Implications from Ultrasonographic Evaluation.
    Battaglia M; Cosenza L; Scotti L; Bertoni M; Polverelli M; Loro A; Santamato A; Baricich A
    Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity.
    Santamato A; Facciorusso S; Spina S; Cinone N; Avvantaggiato C; Santoro L; Ciritella C; Smania N; Picelli A; Gasperini G; Molteni F; Baricich A; Fiore P
    Eur J Phys Rehabil Med; 2021 Jun; 57(3):424-433. PubMed ID: 33263248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.